COVID-19 News

AUSTIN, Texas & NEW YORK--(BUSINESS WIRE)--BrainCheck Inc., a cognitive workflow platform, today highlighted the publication of a peer-reviewed longitudinal study conducted at UTHealth Houston that used BrainCheck to track cognitive outcomes in patients hospitalized for COVID-19 over a 36-month period. The study, published in The Journal of Neuropsychiatry and Clinical Neurosciences, represents one of the largest and longest-running evaluations of cognitive outcomes following COVID-19 hospitali...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a part of Fresenius, and a leading provider of essential medicines and medical technologies, announced today that the Centers for Medicare & Medicaid Services has issued indication-specific Healthcare Common Procedure Coding System (HCPCS) codes for Tyenne® (tocilizumab-aazg) for the treatment of COVID-19. The new codes will be effective for Medicare claims for eligible patients administered Tyenne on April 1, 2026. These new COVID-19 HCPC...

LOS ANGELES--(BUSINESS WIRE)--The AIDS Healthcare Foundation (AHF) is urging governments meeting in Yaoundé, Cameroon, at the WTO 14th Ministerial Conference to ensure the continuation of the longstanding moratorium on certain intellectual property disputes—known as “non-violation complaints”—under the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). This moratorium has helped protect countries from WTO challenges for using TRIPS flexibiliti...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma and COVIRIX Medical collaborate to assess feasibility of adapting Aptar Pharma’s proprietary DPI platform for antiviral delivery....

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced that the Company will participate in the following investor conference, in Miami, Florida: Leerink Partners 2026 Global Healthcare Conference (Fireside Chat) Wednesday, March 11, 2026 (11:20 a.m. ET) Webcast link can be found under Investor Relations/Events secti...

SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced that it will release its financial results for the quarter and year ended December 31, 2025 after the market close on Tuesday, March 3 and will also host a conference call and webcast at 4:30 p.m. Eastern Time on March 3...

OAKLAND, Calif.--(BUSINESS WIRE)--CWCI's review of state data shows employer-reported COVID-19 illness cases led to huge fluctuations in California work injury and illness trends....

TOKYO & OSAKA, Japan--(BUSINESS WIRE)--Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a unique “Self-Testing Service*1” designed to visualize a person’s immune status. Through the KIRIN HEALTH INNOVATION FUND, a corporate venture capital fund jointly established in February 2023 with Global Brain Corporation, one of Japan’s leading independent venture capital firms, Kirin Holdings invested in Immunosens*2 and has been e...

EL SEGUNDO, Calif.--(BUSINESS WIRE)--A federal court ruled MetLife wrongly denied long-term disability benefits, setting a key precedent for long-haul COVID ERISA claims....

BIRMINGHAM, Ala.--(BUSINESS WIRE)--Southern Research and London-based Pathogenus Consulting have signed a three-year partnership that will allow both organizations to capitalize on growing research opportunities around the world. "We’ve seen clear momentum in our work with partners outside the United States, especially with Japan and European pharmaceutical companies, and the opportunity to broaden that footprint is both exciting and timely,” said Fusataka Koide, senior director of global clien...